Search the Newsreel

Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview

Inhibikase Therapeutics, Inc. is projected to report a loss of 11 cents per share in its upcoming earnings. This article serves as an earnings preview, indicating the anticipated financial performance for the company.

Kritika Wires Standalone June 2026 Net Sales at Rs 161.86 crore, down 21.75% Y-o-Y

Pritika Auto Industries Q1 Results: Q1FY27 financials approved by Board

Price Action | Blue Cloud surges 9% on $150 mn order; Ambika Cotton Mills slips 9%

Why Playtika Holding (PLTK) Could Be 42% Undervalued Following Reaffirmed 2026 Guidance

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. How Playtika Holding's latest earnings and guidance frame the stock today Playtika Holding (PLTK) reaffirmed its full year 2026 revenue guidance of US$2.75b to US$2.85b and reported …

Bikaji Foods International Limited Just Missed Earnings - But Analysts Have Updated Their Models

Q1 FY27 results this week: Tata Motors, HAL, Vi, Bharat Forge, RVNL, Ashok Leyland and more; check full list

Obeikan Glass Books Higher H1 Attributable Net Profit, Revenue

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Consensus Recommendation of "Buy" by Brokerages

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) has received a consensus "Buy" recommendation from nine brokerages, with an average 12-month price target of $5.40. The company's shares recently opened at $2.47, up 2.5%, with a market capitalization of $326.11 million. Several institutional investors, including Goldman Sachs Group …

Understanding Momentum Shifts in (ANIK)

This article analyzes Anika Therapeutics Inc. (ANIK) using AI models, highlighting strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three distinct institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for …

Playtika (PLTK) Stock Slides As Margin Repair Meets Revenue Doubts

Playtika (PLTK) stock fell 10.9% after its Q2 2026 earnings release, despite significant margin repair with Adjusted EBITDA rising to 28.2% due to reduced user acquisition spend and increased direct-to-consumer revenue. However, revenue growth was modest at 5% year-over-year and declined sequentially, and active …

Pritika Auto Industries reappoints A.K. Sood & Verma Khushwinder as auditors

Ambika Cotton Mills reappoints P V Chandran as MD for five years

AMBIKCO: Revenue and profit surged year-over-year, with EPS at ₹44.89 and capacity expansion ongoing

Ambika Cotton Q1 Profit Jumps 61% to ₹25.7 Crore

Pritika Auto Industries appoints Ajay Kumar, reappoints two independent directors

Ambika Cotton Mills recommends K. Murali Mohan as independent director

Ambika Cotton Mills re-appoints Vijayalakshmi Narendra as Independent Director

Pritika Auto Industries promotes Ajay Kumar to Joint Managing Director

Pritika Auto Industries Share: ક્વાર્ટર-ઓન-ક્વાર્ટર ધોરણે આવક અને નફામાં વૃદ્ધિ, નવા MDની નિમણૂક

Pritika Auto Industries Posts Sequential Growth in Revenue and Profit

Ambika Cotton Mills Q1 Results: Net Profit Up 61%, EBITDA Margin Expands to 15.28%

Ambika Cotton Mills Q1 FY27 Revenue at ₹258 Cr, PAT ₹25.7 Cr

Playtika (NASDAQ:PLTK) Stock Rating Upgraded by Wall Street Zen

Anika Therapeutics (NASDAQ:ANIK) Raised to Strong-Buy at Zacks Research

Zacks Research has upgraded Anika Therapeutics (NASDAQ:ANIK) to a "strong-buy" rating. This upgrade follows the company's strong quarterly earnings, where EPS of $0.42 significantly beat the $0.03 consensus, and revenue of $32.61 million also exceeded expectations. Institutional investors hold a substantial portion of the …

Anika (ANIK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Stephen D. GriffinSenior Vice President, Chief Accounting Officer, and Treasurer - Ian W. McLeodExecutive Director, Corporate Development and Investor Relations - Matthew …

Anika Therapeutics, Inc. (ANIK) Stock Price, News, Quote & History

This article provides comprehensive financial data for Anika Therapeutics, Inc. (ANIK), including its current stock price, historical performance, and key financial metrics. It details the company's orthopedic products and services, analyst ratings, and comparative data with other companies in the drug manufacturing industry. The …

ANIK (NASDAQ: ANIK) holder plans Form 144 sale of 16,864 shares

An individual holder of Anika Therapeutics, Inc. (ANIK) plans to sell 16,864 shares of common stock on NASDAQ, with an aggregate market value of $355,255.47 as of August 7, 2026, according to a Form 144 filing. The filing also notes recent activity including an …

Playtika Holding Corp. Stock 12‑Month Price Target Cut to $5.1, Implies 31% Upside

Analysts have lowered the average 12-month price target for Playtika Holding Corp. (PLTK) stock to $5.1, down from $5.15. Despite the reduction, this new target still suggests a potential upside of approximately 31% based on the recent closing price. The consensus rating from 13 …

Playtika Holding Corp (PLTK) Stock News Today

KAP *** BORUSAN BİRLEŞİK BORU FABRİKALARI SANAYİ VE TİCARET A.Ş. *** BRSAN *** Geleceğe Dönük Değerlendirmeler

Playtika Q2 2026 revenue up 5% to $731.1m, DTC up 63%

Playtika Holding Corp. reported Q2 2026 revenue of $731.1 million, a 5.0% year-on-year increase, driven by a 63.1% surge in direct-to-consumer (DTC) sales to $286.9 million. The company's adjusted EBITDA rose by 23.4% to $206.1 million, with margins expanding to 28.2%, partly due to …

LIC, Siemens Energy, Crompton Consumer, Bikaji Foods, Aurobindo Pharma Among 10 Stocks Reviewed By HDFC Securities After Q1: Check New Target Prices

Zuleika Gold Issues 113 Million Shares Following $2.26 Million Option Exercise

Zuleika Gold Boosts Capital With $2.26m From Option Exercises

Zuleika Gold Seeks ASX Quotation for 113 Million New Shares